The video below explains why a randomized controlled study is needed to prove the effectiveness of any new drug, and how this applies to nCoV. At the time point of 8:05, he states that the Chinese testing of Remdesivir should be completed by the end of April.
I suggest that we'll be hearing initial results from Biotron's test long before then.
The video below explains why a randomized controlled study is...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
-0.001(0.70%) |
Mkt cap ! $64.06M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.3¢ | 7.0¢ | $37.41K | 526.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 573595 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 20636 | 1 |
View Market Depth
| Last trade - 11.40am 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.1¢ | 7.0¢ | 117824 | ||
| Last updated 11.40am 19/04/2024 ? | |||||
| BIT (ASX) Chart |